Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Convalescent plasma Emergency use authorization Used to treat other disease Other treatment Oct/26/2020 Oct/26/2020 0
Entrectinib Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/21/2020 Oct/17/2020 0
Myricetin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020 Oct/10/2020 0
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
Lifirafenib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Aug/25/2020 0
Montelukast Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/11/2020 Aug/25/2020 0
Radotinib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Aug/25/2020 0
Tivantinib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 Aug/25/2020 0
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020 Aug/25/2020 0